Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities

被引:1604
作者
Sanyal, AJ [1 ]
Campbell-Sargent, C
Mirshahi, F
Rizzo, WB
Contos, MJ
Sterling, RK
Luketic, VA
Shiffman, ML
Clore, JN
机构
[1] Virginia Commonwealth Univ, Med Coll Virginia, Div Gastroenterol Hepatol, Dept Internal Med, MCV Box 980711, Richmond, VA 23298 USA
[2] Virginia Commonwealth Univ, Med Coll Virginia, Dept Pediat, Richmond, VA 23298 USA
[3] Virginia Commonwealth Univ, Med Coll Virginia, Dept Pathol, Richmond, VA 23298 USA
[4] Virginia Commonwealth Univ, Med Coll Virginia, Div Endocrinol, Dept Internal Med, Richmond, VA 23298 USA
关键词
D O I
10.1053/gast.2001.23256
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: The pathogenesis of nonalcoholic steatohepatitis (NASH) is unknown. We tested the hypothesis that NASH is associated with 2 defects: (1) peripheral insulin resistance, which increases lipolysis, delivery of free fatty acids (FFA) to the liver, and hepatic fatty acid beta oxidation, thereby creating oxidative stress; and (2) an abnormality within the hepatocytes that might render them more susceptible to injury from oxidative stress. Methods: The hypothesis was tested by evaluation of (1) insulin resistance by a 2-step hyperinsulinemic (10 and 40 mU . m(-2) min(-1)) euglycemic clamp; (2) insulin effects on lipolysis by enrichment of [U-C-13]glycerol; (3) frequency and severity of structural defects in hepatocyte mitochondria in vivo; (4) fatty acid beta oxidation from serum IF-OH butyrate], release of water-soluble radioactivity from H-3-palmitate by cultured fibroblasts and urinary dicarboxylic acid excretion; and (5) hepatic lipid peroxidation by immunohistochemical staining for 9-nitrotyrosine (3-NT). Subjects with NASH (n = 6-10 for different studies) were compared with those with fatty liver (n = 6) or normal controls (n = 6), Results: HASH and fatty liver were both associated with insulin resistance, with mean glucose infusion rates (normal/fatty liver/NASH) of step 1, 4.5/1,6/0.9; step 2, 9.5/7.7/4.5 (P < 0.03 for both steps). Although baseline rates of glycerol appearance were higher in those with NASH than in those with fatty liver (means, 14.6 vs. 21.6 mu mol . kg(-l) . min(-1); P < 0.05), neither group significantly suppressed glycerol appearance at insulin infusion rates of 10 mU m-2 min-l. NASH was associated with loss of mitochondrial cristae and paracrystalline inclusions in 9 of 10 subjects, compared with 0 of 6 subjects with fatty liver. However, no evidence of a generalized defect in fatty acid P oxidation was noted in any group. Also, mean [beta-OH butyrate] was highest in those with NASH (means, 90 vs. 110 vs. 160 mu mol/L; P < 0,04). Increased staining for 3-NT was present in fatty liver, and even greater staining was seen in NASH. Conclusions: These data indicate that peripheral insulin resistance, increased fatty acid P oxidation, and hepatic oxidative stress are present in both fatty liver and NASH, but HASH alone is associated with mitochondrial structural defects.
引用
收藏
页码:1183 / 1192
页数:10
相关论文
共 47 条
  • [1] 2 CASES FROM THE SPECTRUM OF NONALCOHOLIC STEATOHEPATITIS
    ABDELMALEK, M
    LUDWIG, J
    LINDOR, KD
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 1995, 20 (02) : 127 - 130
  • [2] NONALCOHOLIC STEATOHEPATITIS - AN EXPANDED CLINICAL ENTITY
    BACON, BR
    FARAHVASH, MJ
    JANNEY, CG
    NEUSCHWANDERTETRI, BA
    [J]. GASTROENTEROLOGY, 1994, 107 (04) : 1103 - 1109
  • [3] BAKER A L, 1985, Survey of Digestive Diseases, V3, P154
  • [4] PATHOLOGICAL IMPLICATIONS OF NITRIC-OXIDE, SUPEROXIDE AND PEROXYNITRITE FORMATION
    BECKMAN, JS
    CROW, JP
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 1993, 21 (02) : 330 - 334
  • [5] BONADONNA RC, 1994, AM J PHYSIOL, V266, pE501
  • [6] Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x
  • [7] Mitochondrial abnormalities in non-alcoholic steatohepatitis
    Caldwell, SH
    Swerdlow, RH
    Khan, EM
    Iezzoni, JC
    Hespenheide, EE
    Parks, JK
    Parker, WD
    [J]. JOURNAL OF HEPATOLOGY, 1999, 31 (03) : 430 - 434
  • [8] CARAFOLI E, 1986, ANN NY ACAD SCI, V488, P1
  • [9] CONCURRENT ZIDOVUDINE-INDUCED MYOPATHY AND HEPATOXICITY IN PATIENTS TREATED FOR HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION
    CHEN, SCA
    BARKER, SM
    MITCHELL, DH
    STEVENS, SMB
    ONEILL, P
    CUNNINGHAM, AL
    [J]. PATHOLOGY, 1992, 24 (02) : 109 - 111
  • [10] The association of cardiovascular risk factor clustering related to insulin resistance syndrome (Syndrome X) between young parents and their offspring: the Bogalusa Heart Study
    Chen, W
    Srinivasan, SR
    Elkasabany, A
    Berenson, GS
    [J]. ATHEROSCLEROSIS, 1999, 145 (01) : 197 - 205